UBS Maintains Buy on Pactiv Evergreen, Lowers Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Curt Woodworth maintains a Buy rating on Pactiv Evergreen (NASDAQ:PTVE) but lowers the price target from $19 to $16.

July 17, 2024 | 4:09 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
UBS analyst Curt Woodworth maintains a Buy rating on Pactiv Evergreen but lowers the price target from $19 to $16.
The Buy rating suggests continued confidence in Pactiv Evergreen's long-term prospects, but the lowered price target indicates some short-term concerns or adjustments in valuation. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100